0000899243-16-028840.txt : 20160912
0000899243-16-028840.hdr.sgml : 20160912
20160912215233
ACCESSION NUMBER: 0000899243-16-028840
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160908
FILED AS OF DATE: 20160912
DATE AS OF CHANGE: 20160912
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIEGALL CLAY B
CENTRAL INDEX KEY: 0001167496
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 161881914
MAIL ADDRESS:
STREET 1: 21823 30TH DR SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-09-08
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001167496
SIEGALL CLAY B
21823 30TH DRIVE SE
BOTHELL
WA
98021
1
1
0
0
President and CEO
Common Stock
2016-09-08
4
M
0
31269
10.29
A
648307
D
Common Stock
2016-09-08
4
S
0
31269
50.0808
D
638835
D
Common Stock
2016-09-10
5
G
0
E
6148
0.00
D
0
I
by Trust
Non-Qualified Stock Option (right to buy)
10.29
2016-09-08
4
M
0
31269
0.00
D
2017-08-28
Common Stock
31269
115443
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $50.00 to $50.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
The Reporting Person previously contributed shares of SGEN common stock to a grantor retained annuity trust for the benefit of himself and trusts for his children. Upon the termination of the trust on September 10, 2016, 6,148 of the shares were transferred to the Reporting Person's children's trusts and the remaining 21,797 shares were transferred to the Reporting Person and are included in the reported number of shares directly owned by the Reporting Person.
Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11.
/s/ Jean Liu
2016-09-12